Skip to main navigation Skip to search Skip to main content

Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease

Björn Wikström, Sunil Bhandari, Peter Barany, Philip A Kalra, Søren Ladefoged, Jan Wilske, Lars L Thomsen

    51 Citations (Scopus)

    Abstract

    Patients with chronic kidney disease (CKD) often suffer from iron deficiency anemia necessitating treatment with intravenous iron. This study was designed to assess the safety of iron isomaltoside 1000 (Monofer) in CKD patients. The secondary objective was to assess its effect on iron deficiency anemia.
    Original languageEnglish
    JournalIndian Journal of Nephrology
    Volume24
    Issue number5
    Pages (from-to)589-96
    Number of pages8
    ISSN0971-4065
    Publication statusPublished - 2011

    Keywords

    • Adult
    • Aged
    • Aged, 80 and over
    • Analysis of Variance
    • Anemia, Iron-Deficiency
    • Biological Markers
    • Disaccharides
    • Europe
    • Female
    • Ferric Compounds
    • Ferritins
    • Hematinics
    • Hemoglobins
    • Humans
    • Infusions, Intravenous
    • Injections, Intravenous
    • Iron
    • Kidney Diseases
    • Male
    • Middle Aged
    • Renal Dialysis
    • Time Factors
    • Transferrin
    • Treatment Outcome
    • Young Adult

    Fingerprint

    Dive into the research topics of 'Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease'. Together they form a unique fingerprint.

    Cite this